Literature DB >> 19426866

Acetylation of mitochondrial proteins.

Matthew D Hirschey1, Tadahiro Shimazu, Jing-Yi Huang, Eric Verdin.   

Abstract

Sirtuins (SIRT1-SIRT7) are a family of NAD(+)-dependent protein deacetylases that regulate cell survival, metabolism, and longevity. SIRT3 is localized to the mitochondria where it deacetylates several key metabolic enzymes: acetylcoenzyme A synthetase, glutamate dehydrogenase, and subunits of complex I and thereby regulates their enzymatic activity. SIRT3 is therefore emerging as a metabolic sensor that responds to change in the energy status of the cell via NAD(+) and that modulates the activity of key metabolic enzymes via protein deacetylation. Here we review experimental approaches that can be used in vitro and in vivo to study the role of acetylation in mitochondrial cell biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426866     DOI: 10.1016/S0076-6879(09)05008-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  26 in total

Review 1.  Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.

Authors:  Michael N Sack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

2.  Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1.

Authors:  Iain Scott; Bradley R Webster; Jian H Li; Michael N Sack
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

3.  Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.

Authors:  Sivakama S Bharathi; Yuxun Zhang; Al-Walid Mohsen; Radha Uppala; Manimalha Balasubramani; Emanuel Schreiber; Guy Uechi; Megan E Beck; Matthew J Rardin; Jerry Vockley; Eric Verdin; Bradford W Gibson; Matthew D Hirschey; Eric S Goetzman
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

4.  SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome.

Authors:  Matthew D Hirschey; Tadahiro Shimazu; Enxuan Jing; Carrie A Grueter; Amy M Collins; Bradley Aouizerat; Alena Stančáková; Eric Goetzman; Maggie M Lam; Bjoern Schwer; Robert D Stevens; Michael J Muehlbauer; Sanjay Kakar; Nathan M Bass; Johanna Kuusisto; Markku Laakso; Frederick W Alt; Christopher B Newgard; Robert V Farese; C Ronald Kahn; Eric Verdin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

Review 5.  Mitochondrial fatty acid oxidation in obesity.

Authors:  Dolors Serra; Paula Mera; Maria Ida Malandrino; Joan Francesc Mir; Laura Herrero
Journal:  Antioxid Redox Signal       Date:  2012-10-05       Impact factor: 8.401

Review 6.  Exploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation status and enzymatic activity.

Authors:  Yueming Zhu; Seong-Hoon Park; Ozkan Ozden; Hyun-Seok Kim; Haiyan Jiang; Athanassios Vassilopoulos; Douglas R Spitz; David Gius
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

7.  The structural and functional signatures of proteins that undergo multiple events of post-translational modification.

Authors:  Vikas Pejaver; Wei-Lun Hsu; Fuxiao Xin; A Keith Dunker; Vladimir N Uversky; Predrag Radivojac
Journal:  Protein Sci       Date:  2014-06-11       Impact factor: 6.725

8.  4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification.

Authors:  Kristofer S Fritz; James J Galligan; Rebecca L Smathers; James R Roede; Colin T Shearn; Philip Reigan; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2011-04-14       Impact factor: 3.739

Review 9.  Contribution of mitochondrial oxidative stress to hypertension.

Authors:  Sergey I Dikalov; Anna E Dikalova
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-03       Impact factor: 2.894

Review 10.  Metabolic regulation of Sirtuins upon fasting and the implication for cancer.

Authors:  Yueming Zhu; Yufan Yan; David R Gius; Athanassios Vassilopoulos
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.